We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Global Health | LSE:GHP | London | Ordinary Share | GB00B23TTS84 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 115.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 2339C Global Health Partner PLC 28 August 2008 Global Health Partner plc ('GHP' or the 'Company') Global Health Partner plc Shareholders approve Scheme of Arrangement On 7 July 2008, the board of GHP announced that it had reached a decision to recommend a proposal for the acquisition of the entire issued and to be issued share capital of GHP by a newly incorporated Swedish company ("Global Health Partner AB" or "GHP AB"), on the basis of one GHP AB Share for each GHP Share (the "Offer"). The acquisition is to be effected by means of a scheme of arrangement under part 26 of the Companies Act 2006 which requires the approval of GHP Scheme Shareholders and the sanction of the Court (the "Scheme"). The proposed scheme of arrangement involves a reduction of capital which requires the approval of GHP's Scheme Shareholders by special resolution and the subsequent confirmation of the Court. A circular to GHP Shareholders in connection with the Scheme was published on 4 August 2008 (the 'Scheme Document'). Any capitalised term used but not defined in this announcement is as defined in the Scheme Document. The GHP Independent Director is now pleased to announce that at yesterday's meeting of GHP shareholders convened by the Court, the required majority of GHP shareholders approved the Scheme without modification. At the subsequent Extraordinary General Meeting, also held yesterday, GHP shareholders passed the Special Resolutions which were proposed, as set out in the notice of Extraordinary General Meeting dated 4 August 2008. The number of votes for and against the Scheme at the Court Meeting were as follows: Number of Scheme % of Scheme % of total issued Number of Scheme % of Scheme Shareholders present Shareholders present Scheme Shares Shareholders voted Shareholders present voted who voted in favour who voted in favour For 22 100 60 100 100 Against Nil Nil Nil Nil Nil At the Extraordinary General Meeting, the Special Resolution was passed unanimously on a show of hands. The Scheme and the associated Reduction of Capital will also require the subsequent sanction and (as the case may be) confirmation of the Court. Expected Timetable of Principal Events The following times and dates are indicative only and will depend, amongst other things, on the dates upon which the Court sanctions the Scheme and confirms the Reduction of Capital and whether the Conditions are either satisfied or, if capable of waiver, waived. Last day of dealings in GHP Shares: 16 September 2008 Scheme Record Time: 16 September 2008 (6.00pm) Scheme Court Hearing Date: 15 September 2008 Effective Date of the Scheme: 18 September 2008 Cancellation of GHP Shares: 18 September 2008 Latest date for despatch of Consideration Shares: within 14 days from Effective Date This announcement is not intended to, and does not constitute or form part of any offer to sell or an invitation to purchase or subscribe for any securities pursuant to the Proposal or otherwise or the solicitation of any vote or approval in any jurisdiction. GHP Shareholders are advised to read carefully the formal documentation in relation to the Scheme. Any persons who are subject to the laws of any jurisdiction other than the UK should inform themselves about and observe any applicable requirements. Copies of this announcement are not being, and must not be, directly or indirectly mailed or otherwise forwarded, distributed or sent in or into any jurisdiction where to do so would violate the laws of that jurisdiction and persons receiving this announcement (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or otherwise send it in, or into or from any such jurisdiction. Further details in relation to overseas shareholders are contained in the Scheme Document. This announcement has been prepared in accordance with English Law and the AIM Rules and information disclosed may not be the same as that which would have been prepared in accordance with jurisdictions outside England. The Proposal is subject to the applicable rules and regulations of the Financial Services Authority and the London Stock Exchange. Cenkos Securities, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for GHP and no one else in connection with the Proposal and will not be responsible to anyone other than GHP for providing the protections afforded to clients of Cenkos Securities or for providing advice in relation to the Proposal or any other matters referred to in this announcement. For further information contact: Global Health Partner plc Tel: +44 (0) 20 7665 1833 James Thornton Tel: +46 31 712 53 02 Per Batelson Cenkos (Financial Adviser to Global Health Partner plc) Ivonne CantElizabeth Bowman Tel: +44 (0)20 7397 8900 This information is provided by RNS The company news service from the London Stock Exchange END MSCUWRSRWKRWUAR
1 Year Global Health Chart |
1 Month Global Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions